https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
Results Comparing dabigatran to warfarin, estimated 2-year RDs for ischemic stroke were similar with trial transport and non-experimental methods. However, 2-year mortality RDs were closer to the null when using trial transport versus non-experimental methods for the dabigatran target population (transported RD -0.57%; non-experimental RD -1.9%). Estimated gastrointestinal bleeding RDs from trial transport (dabigatran initiator RD 1.8%; warfarin initiator RD 1.9%) appeared more harmful than non-experimental results (dabigatran
Like
Comment
Share
